来自:中国糖尿病杂志 编辑:洪天配|点击数:|2014-03-26
·研究进展·
【摘要】糖尿病治疗是近年来转化医学领域的热点。地特胰岛素(Det)是以临床需求为导向的基础-临床转化型研究所获得的成果。从实验室研究发现,到临床试验结果,再到临床观察数据,1次/d Det治疗均表现出良好的疗效和安全性,且有避免体重增加的优势。Det是转化医学在T2DM治疗领域的成功案例。
【关键词】转化医学;地特胰岛素;糖尿病,2型
Translational medicine in the development of insulin detemir for treating type 2 diabetes HONG Tian-pei. Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China
【Summary】Anti-diabetic pharmacotherapy is now becoming a hotspot of translational medicine. Insulin detemir is a fruit of directly connecting clinical demands with basic research results. Administration of insulin detemir once daily shows ideal efficacy and safety as well as advantages in avoiding weight gain through the whole developing process from laboratory studies to clinical trials, and then to observational investigation in real world. Therefore, insulin detemir is a successful case of translational medicine in the therapeutics of T2DM.
【Key words】Translational medicine;Insulin detemir;Diabetes mullitus,type 2
版权所有:《中国糖尿病杂志》社 主管单位:中华人民共和国教育部 主办单位:北京大学
地址:北京市西城区大红罗厂街1号 邮编:100034 电话(传真):010-88505683
中国糖尿病杂志社版权所 京ICP备11029051号-1 Powered by JiuduCMS 技术支持:九度创想